Related articles
-
Article
Valeant’s financial restatement begs compliance questions
Valeant Pharmaceuticals’ announced financial restatement raises questions about the drug company’s compliance program and its business model. But it might also serve as an early warning to all publicly listed U.S. companies about the increased room for misjudging the booking of sales once FASB rolls out its new revenue recognition ...
-
News BriefAI hallucinations in Deloitte Australia report highlight important role for compliance
“Hallucinatory” citations and errors in an AI-assisted report produced by Deloitte for the Australian government should be a wake-up call for compliance officers about the risks of placing too much trust in AI.
-
PremiumQ&A with Olga Kozak-Anlar of Robinhood Markets
Compliance Week Editor-in-Chief Aaron Nicodemus recently interviewed Olga Kozak-Anlar, Compliance AI Lead at Robinhood Markets Incorporated, about her role at Robinhood and the company’s use of AI.